According to NYU’s complaint filed in the Southern District of New York, the university sent Resmed chief executive Michael Farrell a letter in early June demanding the health group disable key features of its device within 24 hours. The company did not accede to NYU’s request.
Resmed sells a range of products and masks that help treat sleep apnoea and other conditions. This includes its hugely successful machine to treat sleep apnoea, the AirSense 10 — the device at the center of the NYU lawsuit.
The university is seeking unpaid royalties, interest and costs. The quantum of NYU’s claim is not currently disclosed.
Source: Sydney Morning Herald
